Bioidentical hormone therapy, also known as BHRT, has gained immense popularity in recent years, especially for individuals who experience a decline in hormone production. The therapy involves using hormones that are identical in molecular structure to those produced by the body, yielding fewer adverse side effects than traditional hormone replacements.
In this blog, you’ll explore who should consider getting bioidentical hormone therapy in Tampa, FL.
Perimenopausal and Menopausal Women
Perimenopause and menopause trigger a decline in hormone production, particularly estrogen and progesterone, leading to vaginal dryness, mood swings, hot flashes, and poor sleep. Bioidentical hormone therapy can help alleviate these symptoms.
If you experience these symptoms, it’s wise to consult with our physician who can test your hormone levels and prescribe the right course of treatment.
Individuals with Adrenal Fatigue
Adrenal fatigue results from the body’s inability to restore energy levels and hormones after stress, leading to chronic fatigue, anxiety, insomnia, and difficulty managing stress levels.
Through bioidentical hormone therapy in Tampa, FL individuals with adrenal fatigue can supplement the exhausted hormones, leading to an increase in energy levels, improved immune system, enhanced mood, and less vulnerability to stressors.
Andropausal Men
Andropause, also known as male menopause, occurs when men experience a decline in testosterone production, leading to erectile dysfunction, fatigue, weight gain, anxiety, and depression. Bioidentical hormone therapy can increase testosterone production, resulting in an increase in sexual energy, muscle mass, and reduced body fat.
Individuals with Thyroid Imbalances
The thyroid gland plays a vital role in hormone metabolism; thus, a deficiency or excess production of these hormones may alter the hormone balance, affecting overall well-being. Thyroid imbalances cause hair loss, weight gain, cold intolerance, dry skin, and fatigue. For more information, please visit Premier Image.
